CoChat

Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes

Open access
Charmandari, Evangelia, Kino, Tomoshige · 2010 · European Journal of Clinical Investigation
Cited by 61

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Eur J Clin Invest 2010; 40 (10): 932–942 Background Glucocorticoids regulate a broad spectrum of physiologic functions and play important roles in resting and stress homeostasis. Their actions are mediated by the nuclear glucocorticoid receptor (GR). Design Using a patient as a stimulus, we reviewed briefly the area of Primary Generalized Glucocorticoid Resistance in man and nonhuman primates. Results In man, Primary Generalized Glucocorticoid Resistance is a rare sporadic or familial syndrome characterized by target‐tissue insensitivity to glucocorticoids and compensatory elevations in adrenocorticotropic hormone (ACTH), leading to increased secretion of cortisol and adrenal steroids with mineralocorticoid and/or androgenic activity, and causing hypermineralocorticoidism and hyperandrogenism without Cushing stigmata. The presentation, diagnosis and therapy of this condition are summarized. Many or, most likely, all New World primates have markedly elevated cortisol and ACTH, and resistance to dexamethasone suppression, without any pathology. These primates in fact have ‘pan‐steroid/sterol’ resistance, including all five steroid hormones and 1,25‐dihydroxy‐vitamin D. In humans, the molecular basis of Primary Generalized Glucocorticoid Resistance has been mainly ascribed to recent mutations in the GR gene, which impair glucocorticoid signal transduction. In contrast, in the primates, steroid/sterol signalling systems have adapted under yet unknown selective pressures or genetic drift over many million years. Of course, other molecules of the signaling pathways may also be involved in both states. There are now a host of human states associated with tissue‐specific pathologic glucocorticoid target tissue changes. These include allergic, autoimmune, inflammatory and lymphoproliferative disorders. Conclusions In recognition of Professor George P. Chrousos’ extensive ground‐breaking research in this field, and for the sake of brevity, we propose that ‘Chrousos syndrome’ is used instead of ‘Primary Generalized Familial or Sporadic Glucocorticoid Resistance’.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2362.2010.02336.x

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 30

  1. 10.1172/JCI110565 · DOI · Paper page
  2. 10.7326/0003-4819-119-11-199312010-00009 · DOI · Paper page
  3. 10.1210/jc.2009-2463 · DOI · Paper page
  4. 10.1210/edrv-17-3-245 · DOI · Paper page
  5. 10.1126/stke.3042005pe48 · DOI · Paper page
  6. Karl M, 1996, Cushing’s disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant‐negative glucocorticoid receptor mutation, Proc Assoc Am Physicians, 108, 296
  7. 10.1210/jc.76.3.683 · doi:10.1210/jc.76.3.683 · Paper page
  8. 10.1172/JCI116410 · DOI · Paper page
  9. Kino T, 2001, Pathologic human GR mutant has a transdominant negative effect on the wild‐type GR by inhibiting its translocation into the nucleus: importance of the ligand‐binding domain for intracellular GR trafficking, J Clin Endocrinol Metab, 86, 5600, 10.1210/jcem.86.11.8017 · DOI · Paper page
  10. 10.1046/j.1365-2265.2001.01323.x · DOI · Paper page
  11. 10.1210/jcem.87.4.8379 · doi:10.1210/jcem.87.4.8379 · Paper page
  12. 10.1210/jcem.87.6.8520 · doi:10.1210/jcem.87.6.8520 · Paper page
  13. 10.1210/jc.2003-030450 · DOI · Paper page
  14. 10.1210/jc.2004-1920 · DOI · Paper page
  15. 10.1210/jc.2005-1893 · DOI · Paper page
  16. 10.1210/jc.2006-2830 · DOI · Paper page
  17. Dahlman‐Wright K, 1991, Interaction of the glucocorticoid receptor DNA‐binding domain with DNA as a dimer is mediated by a short segment of five amino acids, J Biol Chem, 266, 3107, 10.1016/S0021-9258(18)49960-7 · DOI · Paper page
  18. Kino T, 2004, Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function, Mol Med, 12, 80, 10.2119/2005-00026.Kino · DOI · Paper page
  19. 10.1073/pnas.091553298 · DOI · Paper page
  20. 10.1126/science.1086185 · DOI · Paper page
  21. 10.1126/science.1123348 · DOI · Paper page
  22. 10.1073/pnas.79.6.2036 · DOI · Paper page
  23. Chrousos GP, 1985, The defective glucocorticoid receptor in man and nonhuman primates, Recent Prog Horm Res, 41, 199
  24. 10.1007/978-1-4684-5101-6 · DOI
  25. 10.1210/jc.84.12.4450 · DOI
  26. 10.1111/j.1749-6632.2009.04988.x · DOI · Paper page
  27. 10.1210/jc.2008-0892 · DOI · Paper page
  28. Ferriman D, 1961, Clinical assessment of body hair growth in women, J Clin Endocrinol Metab, 83, 2694
  29. 10.1136/adc.44.235.291 · DOI · Paper page
  30. 10.1210/jc.85.5.2076 · DOI · Paper page

Cited by

See all 61

Metadata

Authors
Charmandari, E., & Kino, T.
Venue
European Journal of Clinical Investigation
Publisher
Wiley
Published
2010-08-19
Volume
40
Issue
10
Pages
932-942
ISSN
  • 0014-2972 (ISSN-L)
  • 1365-2362
OpenAlex
W1959492836
Cited by
61
References
11
FWCI
3.74
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes. https://app.cochat.ai/papers/10.1111/j.1365-2362.2010.02336.x
The paper
Charmandari, E., & Kino, T. (2010). Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.2010.02336.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.